Shotaro Michinaga Selected Research

FR 139317

1/2018	Delayed Administration of BQ788, an ETB Antagonist, after Experimental Traumatic Brain Injury Promotes Recovery of Blood-Brain Barrier Function and a Reduction of Cerebral Edema in Mice.
1/2014	Amelioration of cold injury-induced cortical brain edema formation by selective endothelin ETB receptor antagonists in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shotaro Michinaga Research Topics

Disease

7	Brain Edema (Cerebral Edema) 01/2021 - 01/2012
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2018
3	Narcolepsy 01/2012 - 01/2010
2	Brain Diseases (Brain Disorder) 01/2019 - 04/2013
2	Nervous System Diseases (Neurological Disorders) 01/2018 - 01/2010
2	Cold Injury 09/2015 - 01/2014
2	Edema (Dropsy) 04/2015 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 01/2012 - 12/2010
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Insulin Resistance 04/2022
1	Gliosis 01/2019
1	Hypersensitivity (Allergy) 09/2018
1	Atopic Dermatitis (Atopic Eczema) 09/2018
1	Brain Ischemia (Cerebral Ischemia) 12/2012
1	Sleep Wake Disorders 01/2012
1	Sleepiness 01/2012
1	Disorders of Excessive Somnolence (Hypersomnia) 12/2010

Drug/Important Bio-Agent (IBA)

5	BQ 788IBA 01/2020 - 01/2014
4	Endothelins (Endothelin)IBA 01/2021 - 01/2014
3	Evans Blue (Blue, Evans)FDA Link 01/2021 - 01/2014
3	Endothelin-1 (Endothelin 1)IBA 01/2021 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2012
3	OrexinsIBA 01/2012 - 01/2010
2	FR 139317IBA 01/2018 - 01/2014
2	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 01/2012
2	IRL 2500IBA 09/2015 - 01/2014
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2012 - 12/2010
2	ropinirole (Requip)FDA LinkGeneric 01/2012 - 12/2010
2	NeuropeptidesIBA 12/2010 - 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 04/2022
1	Angiopoietin-1IBA 01/2020
1	Endothelin Receptor AntagonistsIBA 01/2020
1	ambrisentan FDA Link 01/2020
1	Bosentan (Tracleer)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Vasoconstrictor AgentsIBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 09/2018
1	Claudin-5IBA 01/2017
1	Neutralizing AntibodiesIBA 01/2017
1	Messenger RNA (mRNA)IBA 09/2015
1	Blood Proteins (Serum Proteins)IBA 04/2015
1	Glial Fibrillary Acidic ProteinIBA 01/2014
1	AlbuminsIBA 01/2014
1	ChemokinesIBA 04/2013
1	Vascular Endothelial Growth FactorsIBA 12/2012
1	Pharmaceutical PreparationsIBA 01/2012

Therapy/Procedure

1	Phototherapy (Light Therapy) 09/2018
1	Intravenous Administration 01/2018